69 related articles for article (PubMed ID: 17803064)
1. Treatment of hepatitis C virus infection with human ezrin peptide one (HEP1) in HIV infected patients.
Salamov G; Holms R; Bessler WG; Ataullakhanov R
Arzneimittelforschung; 2007; 57(7):497-504. PubMed ID: 17803064
[TBL] [Abstract][Full Text] [Related]
2. HIV and hepatitis C coinfection.
Matthews GV; Dore GJ
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life.
Cacoub P; Rosenthal E; Halfon P; Sene D; Perronne C; Pol S
J Viral Hepat; 2006 Oct; 13(10):678-82. PubMed ID: 16970599
[TBL] [Abstract][Full Text] [Related]
4. Impact of human immunodeficiency virus infection in patients infected with the hepatitis C virus.
Valle Tovo C; Alves de Mattos A; Ribeiro de Souza A; Ferrari de Oliveira Rigo J; Lerias de Almeida PR; Galperim B; Riegel Santos B
Liver Int; 2007 Feb; 27(1):40-6. PubMed ID: 17241379
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of hepatitis C virus RNA in peripheral blood mononuclear cells in HCV-monoinfection and HIV/HCV-coinfection.
Chary A; Winters MA; Eisen R; Knight TH; Asmuth DM; Holodniy M
J Med Virol; 2012 Mar; 84(3):431-7. PubMed ID: 22246828
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection.
Picchio GR; Nakatsuno M; Boggiano C; Sabbe R; Corti M; Daruich J; Pérez-Bianco R; Tezanos-Pinto M; Kokka R; Wilber J; Mosier D
J Med Virol; 1997 Jun; 52(2):219-25. PubMed ID: 9179772
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
[TBL] [Abstract][Full Text] [Related]
8. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous clearance of HCV in HIV-hepatitis C virus coinfected liver transplant patients: prospective study.
Gutiérrez-Moreno M; Bernal-Bellido C; Suárez-Artacho G; Alamo-Martínez JM; Marín-Gómez LM; Serrano-Díaz-Canedo J; Padillo-Ruiz FJ; Gómez-Bravo MA
Transplant Proc; 2012 Sep; 44(7):2100-2. PubMed ID: 22974923
[TBL] [Abstract][Full Text] [Related]
10. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.
Shire NJ; Horn PS; Rouster SD; Stanford S; Eyster ME; Sherman KE;
Hepatology; 2006 Nov; 44(5):1146-57. PubMed ID: 17058240
[TBL] [Abstract][Full Text] [Related]
11. Ribavirin priming improves the virological response to antiviral treatment in transplanted patients with recurrent hepatitis C: a pilot study.
Merli M; Giannelli V; Gentili F; Giusto M; Simmaco M; Lionetto L; Corradini SG; Biliotti E; Attili AF; Rossi M; Taliani G
Antivir Ther; 2011; 16(6):879-85. PubMed ID: 21900720
[TBL] [Abstract][Full Text] [Related]
12. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir.
Sherman KE; Shire NJ; Cernohous P; Rouster SD; Omachi JH; Brun S; Da Silva B
Clin Infect Dis; 2005 Oct; 41(8):1186-95. PubMed ID: 16163639
[TBL] [Abstract][Full Text] [Related]
13. Evaluation and treatment of hepatitis C in patients with human immunodeficiency virus.
Bakaj G; Valasiuk T; Prabhukhot R; Siraj D
South Med J; 2012 Oct; 105(10):500-3. PubMed ID: 23038477
[TBL] [Abstract][Full Text] [Related]
14. The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus.
Flisiak R; Horban A; Gallay P; Bobardt M; Selvarajah S; Wiercinska-Drapalo A; Siwak E; Cielniak I; Higersberger J; Kierkus J; Aeschlimann C; Grosgurin P; Nicolas-Métral V; Dumont JM; Porchet H; Crabbé R; Scalfaro P
Hepatology; 2008 Mar; 47(3):817-26. PubMed ID: 18302285
[TBL] [Abstract][Full Text] [Related]
15. Ezrin Peptide Therapy from HIV to COVID: Inhibition of Inflammation and Amplification of Adaptive Anti-Viral Immunity.
Holms RD; Ataullakhanov RI
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769119
[TBL] [Abstract][Full Text] [Related]
16. No reduction of HCV viral load in HIV patients co-infected with HCV genotype 1 during a 30 days course of nitazoxanide monotherapy.
Laufer N; Abusamra L; Bolcic F; Gun A; Rolón MJ; Pérez H; Krolewiecki A; Salomón H; Quarleri J; Cahn P
Antiviral Res; 2011 Dec; 92(3):497-9. PubMed ID: 22020160
[TBL] [Abstract][Full Text] [Related]
17. Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation period.
Mariño Z; Crespo G; D'Amato M; Brambilla N; Giacovelli G; Rovati L; Costa J; Navasa M; Forns X
J Hepatol; 2013 Mar; 58(3):415-20. PubMed ID: 23063567
[TBL] [Abstract][Full Text] [Related]
18. Virus dynamics and immune responses during treatment in patients coinfected with hepatitis C and HIV.
Talal AH; Shata MT; Markatou M; Dorante G; Chadburn A; Koch R; Neumann AU; Ribeiro RM; Perelson AS
J Acquir Immune Defic Syndr; 2004 Feb; 35(2):103-13. PubMed ID: 14722440
[TBL] [Abstract][Full Text] [Related]
19. In vivo effects of fluvastatin on HCV replication in HIV-1 coinfected subjects.
Milazzo L; Antinori S
J Viral Hepat; 2010 Mar; 17(3):228. PubMed ID: 19758276
[No Abstract] [Full Text] [Related]
20. A randomized trial of Chinese herbal medicines for the treatment of symptomatic hepatitis C.
Jakkula M; Boucher TA; Beyendorff U; Conn SM; Johnson JE; Nolan CJ; Peine CJ; Albrecht JH
Arch Intern Med; 2004 Jun; 164(12):1341-6. PubMed ID: 15226169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
